Systemic adverse effects of ophthalmic beta-blockers. - Wikidata - awgldk - TriplyDB

Systemic adverse effects of ophthalmic beta-blockers.

Systemic adverse effects of ophthalmic beta-blockers.

http://www.wikidata.org/entity/Q34495770

about

Management and Prevention of Anaphylaxis Outpatient Emergencies: Anaphylaxis.Syncope and falls due to timolol eye drops.Evaluation of risk of falls and orthostatic hypotension in older, long-term topical beta-blocker users.The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical Market.Adverse Events in Young and Preterm Infants Receiving Topical Timolol for Infantile Hemangioma.Managing glaucoma in those with co-morbidity: not as easy as it seems.Pharmacodynamic profile of mydriatic agents delivered by ocular piezo-ejection microdosing compared with conventional eyedropper.Evaluation of major depressive disorder in patients receiving chronic treatment with topical timolol.High-precision piezo-ejection ocular microdosing: Phase II study on local and systemic effects of topical phenylephrine.

P2860

Q26766190-9D93A731-D027-4EE8-A6EB-82CB1F414C4E Q30234969-A468C648-50C8-43EA-8AA2-D8D51504D9CB Q33153745-FD24C71F-0FFE-44FC-AEB6-811BF076993F Q37288495-521C5EC2-0B40-4E41-B93D-060E13D7623D Q39227810-5B02EE5C-3FC2-4D12-91D5-F65241A6CADE Q40725867-D69480CE-F045-4E2A-8C5B-8D6FD1C40B00 Q45148188-28045CBA-C26F-444F-8918-213B6A3ADEA9 Q46968848-80518030-8634-48DE-B05E-50C504BAA98E Q48807197-43868040-5EC5-4F65-9D6F-CCB31256F3B3 Q50094851-FFFD1778-3900-49E1-8036-BB1E84A3FADB

P2860

Systemic adverse effects of ophthalmic beta-blockers.

http://www.wikidata.org/entity/Q34495770

description

2001 nî lūn-bûn

@nan

2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Systemic adverse effects of ophthalmic beta-blockers.

@ast

Systemic adverse effects of ophthalmic beta-blockers.

@en

Systemic adverse effects of ophthalmic beta-blockers.

@nl

type

label

Systemic adverse effects of ophthalmic beta-blockers.

@ast

Systemic adverse effects of ophthalmic beta-blockers.

@en

Systemic adverse effects of ophthalmic beta-blockers.

@nl

prefLabel

Systemic adverse effects of ophthalmic beta-blockers.

@ast

Systemic adverse effects of ophthalmic beta-blockers.

@en

Systemic adverse effects of ophthalmic beta-blockers.

@nl

P1433

Q34495770-36EAFD40-56B4-41C4-8B6F-4478C725D34F

P1476

Q34495770-14ED9DAD-557F-4B5F-AC04-4C5FAB98779F

P2093

Q34495770-1C0CD7B0-0556-4BB1-B1E7-3CBF4192AACB

Q34495770-5FD067E6-A284-4F5B-B6EF-D6BB0442A465

Q34495770-707E5A04-B0F8-45BA-950B-A9BDDB4F735D

Q34495770-7CF61920-072D-4D8B-A18F-9792632171F2

Q34495770-A592540A-959E-4B7C-B044-42719563DBA9

Q34495770-D1ECE7C3-EF5E-4E02-B2D5-364BDD2E5F0D

P2860

Q34495770-04522A40-9D38-420A-9015-5CE74C109DC4

Q34495770-12D5DB5B-548F-40D7-8326-9790FBCD8B69

Q34495770-2133581A-CB43-4BE4-9EA1-2328758141B8

Q34495770-3EF03EEA-7924-4235-B893-7C86E583C9C0

Q34495770-57491EDB-93A8-49C1-B0A3-961A55CC1036

Q34495770-6AC3AEA3-8255-4781-8C8F-9C922351A927

Q34495770-7CA63405-D2D2-40E4-8542-8FB71970883B

Q34495770-913F5F6F-09EB-49A2-B76B-E3024523EB73

Q34495770-92DBB8BC-8FCA-4C28-A13E-3AD238202F37

Q34495770-97154147-A2F7-4AF3-929F-CB2ED816CC24

P304

Q34495770-51A21D55-AAE9-48B8-9132-5C38E03F3A76

P31

Q34495770-83CB582B-A412-42AA-AC85-C7C34757A251

P356

Q34495770-26929F09-74EB-4024-95DD-3D55BB2689CB

P407

Q34495770-60A4270A-4683-4FDC-BD62-8CC6F9BB64DC

P433

Q34495770-52E3851D-04B3-4378-B532-F6866C27334E

P478

Q34495770-7657ED55-1227-4498-AC9F-6CF72E6053E3

P577

Q34495770-F2499559-E035-43DD-B87F-E208FFA74A9D

P5875

Q34495770-EB7CBBC2-8CB7-4F9F-9F62-60D117D08695

P698

Q34495770-6C232A93-47CC-4DFF-A840-1D94B3787F0E

P356

P1433

Annals of Pharmacotherapy

P1476

Systemic adverse effects of ophthalmic beta-blockers.

@en

P2093

C Anderson

http://www.w3.org/2001/XMLSchema#string

C L Bunch

http://www.w3.org/2001/XMLSchema#string

G I Wortman

http://www.w3.org/2001/XMLSchema#string

J A Vander Zanden

http://www.w3.org/2001/XMLSchema#string

J I Perlman

http://www.w3.org/2001/XMLSchema#string

R J Valuck

http://www.w3.org/2001/XMLSchema#string

P2860

Beta-blocker eyedrops and nocturnal arterial hypotension

A method for estimating the probability of adverse drug reactions

Developing evidence-based clinical practice guidelines: lessons learned by the US Preventive Services Task Force.

Syncope, bradycardia, and atrioventricular block associated with topical ophthalmic levobunolol.

Topical timolol and serum lipoproteins.

Randomised, controlled trial of spirometric changes in elderly people receiving timolol or betaxolol as initial treatment for glaucoma.

Immunizations, immunoprophylaxis, and chemoprophylaxis to prevent selected infections. US Preventive Services Task Force.

Acute pulmonary edema associated with ocular metipranolol use.

Instruments for assessing the quality of drug studies published in the medical literature.

Bronchial and cardiovascular effects of ocular topical B-antagonists in asthmatic subjects: comparison of timolol, carteolol, and metipranolol.

P304

1633-1637

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1345/APH.18464

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

2001-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

238264598

http://www.w3.org/2001/XMLSchema#string

P698

11793633

http://www.w3.org/2001/XMLSchema#string